Cargando…

Ion channels as convergence points in the pathology of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a fatal disease of the cardiopulmonary system that lacks curative treatments. The main pathological event in PAH is elevated vascular resistance in the pulmonary circulation, caused by abnormal vasoconstriction and vascular remodelling. Ion channels are key d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jouen-Tachoire, Thibault R. H., Tucker, Stephen J., Tammaro, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421048/ https://www.ncbi.nlm.nih.gov/pubmed/34346486 http://dx.doi.org/10.1042/BST20210538

Ejemplares similares

TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR
por: Maron, Bradley A., et al.
Publicado: (2018)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
por: Lambert, Mélanie, et al.
Publicado: (2018)

Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension
por: Alotaibi, Mona, et al.
Publicado: (2023)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Converging on the Origins of Axonal Ion Channel Clustering
por: Rasband, Matthew N.
Publicado: (2009)

Are AD-Typical Regions the Convergence Point of Multiple Pathologies?
por: Villeneuve, Sylvia, et al.
Publicado: (2015)

Polymodal Control of TMEM16x Channels and Scramblases
por: Agostinelli, Emilio, et al.
Publicado: (2022)

Pathological function of Ca(2+)-sensing receptor in pulmonary arterial hypertension
por: Yamamura, Aya
Publicado: (2014)

Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
por: Tamura, Yuichi, et al.
Publicado: (2023)

Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels
por: Firth, Amy L., et al.
Publicado: (2011)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

The mechanism of ions in pulmonary hypertension
por: Liu, Guogu, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Emerging Metabolic Therapies in Pulmonary Arterial Hypertension
por: Harvey, Lloyd D., et al.
Publicado: (2017)

Structural Convergence Among Diverse, Toxic β-Sheet Ion Channels
por: Jang, Hyunbum, et al.
Publicado: (2010)

Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension
por: Hiraishi, Keizo, et al.
Publicado: (2022)

Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021)

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

NAADP‐induced intracellular calcium ion is mediated by the TPCs (two‐pore channels) in hypoxia‐induced pulmonary arterial hypertension
por: Hu, Wen, et al.
Publicado: (2021)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension: Pathophysiology and Treatment
por: Lan, Norris S. H., et al.
Publicado: (2018)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Ion Channels in The Pathogenesis of Endometriosis: A Cutting-Edge Point of View
por: Riemma, Gaetano, et al.
Publicado: (2020)

Pulmonary arterial hypertension-associated changes in gut pathology and microbiota
por: Sharma, Ravindra K., et al.
Publicado: (2020)

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Pathogenic Role of Store-Operated and Receptor-Operated Ca(2+) Channels in Pulmonary Arterial Hypertension
por: Fernandez, Ruby A., et al.
Publicado: (2012)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Redox Regulation of Ion Channels in the Pulmonary Circulation
por: Olschewski, Andrea, et al.
Publicado: (2015)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report
por: Hirakawa, Kyoko, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling?
por: Egom, Emmanuel Eroume-A
Publicado: (2019)

Selexipag in the management of pulmonary arterial hypertension: an update
por: Coghlan, J Gerry, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_87ti6nevlm3s8psrkfvoqgokf2